+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients



Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients



American Journal of Gastroenterology 94(1): 159-163



Objective: Liver biopsies in hepatitis C virus (HCV)-positive end stage renal disease (ESRD) patients before or after renal transplantation were compared to study the effect of transplant-related immunosuppression. Methods: In this prospective study all patients on the active transplant list and all patients with functioning renal transplants at our hospital were tested for HCV antibody (ELISA-2) over a 30-month period. HCV infection was confirmed by polymerase chain reaction in most patients. All HCV-positive patients were asked to undergo liver biopsy without regard to serum transaminase levels. Patients were interviewed, examined, and had detailed chart review. By protocol, liver histology was evaluated according to stage and inflammatory activity in a blinded fashion. Results: There were 129 HCV-antibody-positive patients, of 795 tested. Sixty-seven agreed to liver biopsy. Of these, 22 patients had never been transplanted and 45 had received transplants. Mean transplant duration be fore biopsy was 41.2 months (range, 1-204 months). Transplant patients had significantly longer duration of ESRD and estimated duration of HCV infection than patients not transplanted. Dialysis patients had significantly more portal inflammatory activity and lymphoid follicles on biopsy whereas transplant patients had more piecemeal necrosis and steatosis. However, the total histological activity score and stage were similar between groups. Multivariate analysis confirmed the association between transplant and steatosis. But independent variables including transplant duration, HCV infection duration, and ESRD duration were not correlated with histological findings. Conclusion: Renal transplantation may not be associated with an increased risk of progressive liver disease in HCV-positive patients, compared with ESRD patients receiving chronic dialysis. Long-term studies with serial liver biopsies are needed to resolve this issue.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010357448

Download citation: RISBibTeXText

PMID: 9934748

DOI: 10.1016/s0002-9270(98)00669-8


Related references

Hepatitis C infection in renal transplant recipients Histology and clinical features. Journal of the American Society of Nephrology 5(3): 1006, 1994

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. American Journal of Kidney Diseases 42(1): 184-192, 2003

Long-term ribavirin therapy in hepatitis C virus positive renal transplant patients Effects upon renal function and liver histology. Nephrology Dialysis Transplantation 17(Abstracts Supplement 1): 46, 2002

Transplant liver biopsy in useful to predict clinical outcomes after renal transplantation in hepatitis C positive recipients. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 713A, Sept, 1998

Correlation between liver histology, hepatitis C virus RNA and HCV genotypes in renal transplant patients with antibodies anti-HCV positive. Journal of the American Society of Nephrology 6(3): 1106, 1995

Treatment of chronic hepatitis C in dialysis patients and renal transplant recipients Clinical experience of interferon-alpha. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 196A, Sept, 1997

Clinical and histologic features in hepatitis C infected renal transplant and dialysis patients. Journal of the American Society of Nephrology 6(3): 1086, 1995

Liver histology in renal allograft recipients with chronic hepatitis C and without pre-transplant evidence of liver disease. Hepatology 30(4 PART 2): 456A, 1999

Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 51(2): 391-396, 1991

The clinical significance of renal cell carcinoma in dialysis dependent patients in comparison with kidney transplant recipients. Der Urologe. Ausg. a 36(2): 126-129, 1997

Hepatitis C virus infection in renal transplant recipients Prevalence histology and clinical characteristics. Journal of the American Society of Nephrology 4(3): 937, 1993

Renal disease in hepatitis C-positive liver transplant recipients. Transplantation 63(9): 1287-1293, 1997

Lack of progression of liver disease in hepatitis c positive renal transplant recipients. Gastroenterology 102(4 PART 2): A867, 1992

Clinical course of hepatitis B and hepatitis C liver disease in renal transplant recipients. Journal of the American Society of Nephrology 4(3): 967, 1993

Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation 97(2): 133-137, 2014